Sage Therapeutics, Inc.·4

Jan 4, 4:07 PM ET

IGUCHI KIMI 4

4 · Sage Therapeutics, Inc. · Filed Jan 4, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
IGUCHI KIMI
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2024-01-02$1.36/sh+1,642$2,23370,429 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-01-021,6420 total
    Exercise: $1.36Exp: 2024-01-22Common Stock (1,642 underlying)
Footnotes (1)
  • [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.

Documents

2 files